PERSONALITY TRAITS CORRELATE WITH DISEASE ACTIVITY IN PRIMARY SJOGREN'S SYNDROME

被引：0
|
作者：
Modis, L. [1 ]
Aradi, Z. [2 ]
Horvath, I. F. [2 ]
Szanto, A. [2 ]
Bugan, A. [1 ]
机构：
[1] Univ Debrecen, Dept Behav Sci, Fac Med, Debrecen, Hungary
[2] Univ Debrecen, Div Clin Immunol, Dept Internal Med, Fac Med, Debrecen, Hungary
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2022年 / 40卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
175
引用
收藏
页码：94 / 94
页数：1
相关论文
共 50 条
  • [21] CLINICAL STUDY OF THE DISEASE ACTIVITY AND IMMUNE SCREENING OF PRIMARY SJOGREN'S SYNDROME
    Yin Xufang
    Zhang Mingxing
    Ming Yan
    Li Xiao-Feng
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1746 - 1747
  • [22] VITAMIN D LEVELS AND THE CORRELATION WITH DISEASE ACTIVITY IN PRIMARY SJOGREN'S SYNDROME
    Yilmaz, Z.
    Karabulut, G.
    Kitapcioglu, G.
    Kabasakal, Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 909 - 909
  • [23] IMPACT OF SYMPTOMS AND DISEASE ACTIVITY ON QUALITY OF LIFE IN PRIMARY SJOGREN'S SYNDROME
    Dias, L. H.
    Miyamoto, S. T.
    Valim, V.
    Altoe, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 812 - 812
  • [24] VALIDATION OF EULAR PRIMARY SJOGREN'S SYNDROME DISEASE ACTIVITY AND PATIENT INDEXES
    Seror, R.
    Theander, E.
    Brun, J.
    Ramos-Casals, M.
    Valim, V.
    Doerner, T.
    Mariette, X.
    Bootsma, H.
    Tzioufas, A.
    Solans Laque, R.
    Mandl, T.
    Gottenberg, J. -E.
    Hachulla, E.
    Ng, W. -F.
    Bombardieri, S.
    Gerli, R.
    Sumida, T.
    Saraux, A.
    Tomsic, M.
    Caporali, R.
    Priori, R.
    Moser, K.
    Kruize, A. A.
    Vollenweider, C.
    Ravaud, P.
    Praprotnik, S.
    Scofield, H.
    Valesini, G.
    Montecucco, C.
    Fauchais, A. L.
    Vitali, C.
    Bowman, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 476 - 477
  • [25] Early respiratory disease activity is risk for damage in primary Sjogren's syndrome
    Valim, Valeria
    Sardenberg, Wildner M.
    Caser, Larissa Carvalho
    Santos, Maria Carmen L. F. S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (03) : S261 - S261
  • [26] Defining disease activity states and clinically meaningful improvement in primary Sjogren's syndrome with EULAR primary Sjogren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI)
    Seror, Raphaele
    Bootsma, Hendrika
    Saraux, Alain
    Bowman, Simon J.
    Theander, Eike
    Brun, Johan G.
    Baron, Gabriel
    Le Guern, Veronique
    Devauchelle-Pensec, Valerie
    Ramos-Casals, Manel
    Valim, Valeria
    Doerner, Thomas
    Tzioufas, Athanasios
    Gottenberg, Jacques -Eric
    Laque, Roser Solans
    Mandl, Thomas
    Hachulla, Eric
    Sivils, Kathy L.
    Ng, Wan-Fai
    Fauchais, Anne-Laure
    Bombardieri, Stefano
    Priori, Roberta
    Bartoloni, Elena
    Goeb, Vincent
    Praprotnik, Sonja
    Sumida, Takayuki
    Nishiyama, Sumusu
    Caporali, Roberto
    Kruize, Aike A.
    Vollenweider, Cristina
    Ravaud, Philippe
    Meiners, Petra
    Brito-Zeron, Pilar
    Vitali, Claudio
    Mariette, Xavier
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (02) : 382 - 389
  • [27] Treatment of patients with primary Sjogren's syndrome with rituximab is efficient according to the EULAR Sjogren's Syndrome Disease Activity Index (ESSDAI)
    Vissink, A.
    Moerman, R. V.
    Arends, S.
    Meiners, P. M.
    Meijer, J. M.
    Kroese, F. G. M.
    Spijkervet, F. K. L.
    Bootsma, H.
    ORAL DISEASES, 2012, 18 : 12 - 12
  • [28] Correlation of serum adenosine deaminase activity with disease activity in patients with primary Sjogren's syndrome
    Zhang, Hairong
    Ye, Hongling
    Xu, Zhiye
    Dong, Kunzhan
    Wang, Ying
    Geng, Linyu
    Wang, Sen
    IMMUNOLOGY LETTERS, 2023, 258 : 1 - 7
  • [29] Persistent serological activity in primary Sjogren's syndrome
    Lopez-Morales, Jorge
    Cortes-Munoz, Daniel
    Astudillo-Angel, Miguel
    Hernandez-Molina, Gabriela
    CLINICAL RHEUMATOLOGY, 2020, 39 (03) : 919 - 923
  • [30] Primary Sjogren's syndrome: Functional activity of adrenal
    Martusevich, NA
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 351 - 351
12345